Loading clinical trials...
Loading clinical trials...
A Randomised, Single-blind, Placebo-controlled, Single-centre, Phase I Study in Abdominally Obese Healthy Volunteers to Evaluate Methods to Assess 11-βHSD1 Activity in Adipose Tissue and Related Downstream Biomarkers After Single and Repeated Oral Doses of AZD4017 for 10 Days
Conditions
Interventions
AZD4017
Placebo
Locations
1
Sweden
Research Site
Gothenburg, Sweden
Start Date
March 1, 2010
Primary Completion Date
May 1, 2010
Completion Date
May 1, 2010
Last Updated
December 10, 2010
NCT07472881
NCT01143454
NCT07010757
NCT06223555
NCT06989203
NCT07237750
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions